BORA PHARMACEUTICALS LTD (6472) — Free Cash Flow Generation Index
BORA PHARMACEUTICALS LTD (6472) has a Free Cash Flow Generation Index of 0.83x as of December 2025. Free cash flow of NT$968.90 Million represents 1% of operating cash flow (NT$1.17 Billion). See 6472 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BORA PHARMACEUTICALS LTD Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. Explore 6472 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year Free Cash Flow Generation Index for BORA PHARMACEUTICALS LTD. For the full company profile including market capitalisation, see BORA PHARMACEUTICALS LTD market cap and net worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | NT$3.31 Billion | NT$4.24 Billion | NT$928.67 Million | ▲ +160.8% |
| 2024 | 0.30x | NT$293.76 Million | NT$980.81 Million | NT$687.05 Million | ▼ -56.6% |
| 2023 | 0.69x | NT$3.18 Billion | NT$4.61 Billion | NT$1.43 Billion | ▼ -23.4% |
| 2022 | 0.90x | NT$1.81 Billion | NT$2.01 Billion | NT$200.22 Million | ▲ +27.5% |
| 2021 | 0.71x | NT$873.05 Million | NT$1.24 Billion | NT$363.58 Million | ▲ +388.4% |
| 2020 | 0.14x | NT$25.70 Million | NT$177.79 Million | NT$152.09 Million | ▲ +107.2% |
| 2019 | -2.01x | NT$-465.56 Million | NT$231.77 Million | NT$697.33 Million | — |